Rekombinanter APP (Donanemab Biosimilar) Antikörper
Research Grade
Reaktivität: Human
ELISA, WB
Wirt: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target
- APP (Donanemab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
- Wirt
-
Mammalian Cells
- Expressionssystem
- Mammalian cells
- Klonalität
- Monoklonal
- Applikation
- ELISA, Western Blotting (WB)
- Verwendungszweck
- Donanemab Biosimilar - Anti-APP mAb
- Produktmerkmale
- Antibody Type: IgG1-kappa
- Aufreinigung
- Recombinant antibody expressed in mammalien cells and purified.
- Güteklasse
- Research Grade
- Isotyp
- IgG1 kappa
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS buffer pH 7.5
- Lagerung
- -80 °C
- Informationen zur Lagerung
- store at -80°C
-
- Target
- APP (Donanemab Biosimilar)
- Substanzklasse
- Biosimilar
- Hintergrund
-
LY3002813
Donanemab is a humanized IgG1 monoclonal antibody directed at an N‐terminal pyroglutamate amyloid beta (Aβ) epitope. Donanemab has the potential for early Alzheimer's disease research.
-
Sie sind hier:
